WGS

GeneDx Holdings Corp. Class A · NASDAQ

Sector Health Services
Industry Medical/Nursing Services
Website genedx.com
Employees(FY) -
ISIN US81663L2007

Performance

-9.88%

-8.61%

-15.88%

+132.29%

-8.94%

YTD

+1717.92%

Profile

GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It also provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. is headquartered in Stamford, Connecticut.

Advanced Technical Analysis

Technical Analysis of WGS 2025-02-03

The stock indicators reflect a bearish sentiment overall, with the Moving Average Score at 30, the Oscillators Score at 40, and the Technical Score at 33. This combination suggests a lack of upward momentum and potential weakness in the stock's performance.

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of WGS

Stock Rank

Recent News & Updates

2025-01-28 16:30
GeneDx to Report Fourth Quarter and Full Year 2024 Financial Results on Tuesday, February 18, 2025(Business Wire)
2025-01-28 03:30
GeneDx to Report Fourth Quarter and Full Year 2024 Financial Results on Tuesday, February 18, 2025(Businesswire)
2025-01-20 05:43
Institutional owners may ignore GeneDx Holdings Corp.'s (NASDAQ:WGS) recent US$427m market cap decline as longer-term profits stay in the green(Simply Wall St.)
2025-01-17 16:30
GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)(Business Wire)
2025-01-17 03:30
GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)(Businesswire)
2025-01-14 09:25
GeneDx raises Q4 adjusted gross margin view to 68% from 64%(TipRanks)
2025-01-13 08:30
GeneDx Announces Preliminary 2024 Financial Results(Business Wire)
2025-01-12 19:30
GeneDx Announces Preliminary 2024 Financial Results(Businesswire)
2025-01-12 19:30
GeneDx Announces Preliminary 2024 Financial Results(Businesswire)
2025-01-10 15:24
Outlook For These Biotechs Brightens As FDA Ushers In New Rules For Sector(Investor's Business Daily)
2025-01-09 08:30
GeneDx Introduces New Telehealth Pathway to Expand Access to Exome Testing for Parents Seeking Answers(Business Wire)
2025-01-08 19:30
GeneDx Introduces New Telehealth Pathway to Expand Access to Exome Testing for Parents Seeking Answers(Businesswire)
2025-01-08 08:30
GeneDx Continues its Leadership in Genomics Research, Refining Gene-Disease Relationships and Impacting Results of >22,000 Patients(Business Wire)
2025-01-07 19:30
GeneDx Continues its Leadership in Genomics Research, Refining Gene-Disease Relationships and Impacting Results of +gt;22,000 Patients(Businesswire)
2025-01-07 19:30
GeneDx Continues its Leadership in Genomics Research, Refining Gene-Disease Relationships and Impacting Results of >22,000 Patients(Businesswire)
2025-01-06 16:04
IBD 50's GeneDx Adds To Nearly 2,700% Sprint With FDA Guide On AI(Investor's Business Daily)
2025-01-06 00:39
IBD 50's GeneDx Surges On FDA Recommendations For AI Device Development(Yahoo Finance)
2025-01-03 19:00
Meta Stock, Energy Plays Lead Five Leaders Rebounding Bullishly(Yahoo Finance)
2025-01-02 16:01
GeneDx Strengthens Executive Leadership Team with Bryan Dechairo Named Chief Operating Officer(Business Wire)
2025-01-02 03:01
GeneDx Strengthens Executive Leadership Team with Bryan Dechairo Named Chief Operating Officer(Businesswire)
2024-12-30 13:00
How IBD Stock Of The Day GeneDx Landed On The IBD 50 And Notched A 2,500% Gain(Investor's Business Daily)
2024-12-16 16:05
GeneDx to Present at the 43rd Annual J.P. Morgan Healthcare Conference(Business Wire)
2024-12-16 03:05
GeneDx to Present at the 43rd Annual J.P. Morgan Healthcare Conference(Businesswire)
2024-12-10 05:47
GeneDx Holdings Corp. (NASDAQ:WGS): Is Breakeven Near?(Simply Wall St.)
2024-12-05 08:30
GeneDx to Expand Access to Exome Testing for Pediatric Epilepsy Patients with New Partners(Business Wire)
2024-12-04 19:30
GeneDx to Expand Access to Exome Testing for Pediatric Epilepsy Patients with New Partners(Businesswire)
2024-11-25 13:26
This Once Ultracheap Biotech Stock Rockets 2,762%, Nears Buy Point After Big Earnings Win(Investor's Business Daily)
2024-11-22 16:05
GeneDx to Participate in Upcoming Investor Conference(Business Wire)
2024-11-22 03:05
GeneDx to Participate in Upcoming Investor Conference(Businesswire)
2024-11-20 06:11
Daily – Vickers Top Buyers & Sellers for 11/20/2024(Argus Research)

Page 1 of 6

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.